Eye Diseases "Treated" with Interoperable Medical Informatics

Launched by UNIVERSITY HOSPITAL MUENSTER · Jan 30, 2025

Keywords

ClinConnect Summary

The EyeMatics trial is focused on improving treatments for eye diseases that require injections into the eye, a procedure known as intravitreal injections. The goal of this study is to create a better system for sharing and analyzing patient data from clinical research, which will help doctors provide more personalized care for patients with eye conditions. Importantly, the trial involves input from patients themselves to ensure their experiences and concerns are considered in the research process.

If you are between the ages of 65 and 74 and have undergone the specific procedure for eye injections, you may be eligible to participate in this trial. Participants can expect to engage in a study that uses real patient data to better understand how effective current treatments are and to develop tools that help visualize and analyze this information. This research is being conducted at several hospitals, and by taking part, you could contribute to advancements in eye care that may benefit many others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • OPS code: "5-156.9 Injection of drugs into the posterior segment of the eye"